These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives]. Bigot F; Bonnet C; Massard C Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355 [TBL] [Abstract][Full Text] [Related]
26. Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America. Grubb RL; Behari A; Kim CM; Williams CR; Linehan WM; Coleman JA J Urol; 2005 Dec; 174(6):2330-3. PubMed ID: 16280834 [TBL] [Abstract][Full Text] [Related]
27. Palliative care in urology. Wu JN; Meyers FJ; Evans CP Surg Clin North Am; 2011 Apr; 91(2):429-44, x. PubMed ID: 21419262 [TBL] [Abstract][Full Text] [Related]
28. The challenges of managing urological malignancy in the elderly. Abu-Ghanem Y; Dhesi JK; Challacombe BJ BJU Int; 2014 Jul; 114(1):12-5. PubMed ID: 24417883 [No Abstract] [Full Text] [Related]
29. Challenging treatment decision-making in older urologic cancer patients. Ploussard G; Albrand G; Rozet F; Lang H; Paillaud E; Mongiat-Artus P World J Urol; 2014 Apr; 32(2):299-308. PubMed ID: 23990122 [TBL] [Abstract][Full Text] [Related]
31. Potential use of RNA interference as therapeutic strategy in urologic cancer. Green WJ; James PA; Ratan HL Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681 [No Abstract] [Full Text] [Related]
33. Controversies in urologic oncology. Dreicer R; See W; Williams R Iowa Med; 1991 Aug; 81(8):343-5. PubMed ID: 1938300 [No Abstract] [Full Text] [Related]
34. Genitourinary cancer in the elderly. Mulholland SG; Stefanelli JL Am J Kidney Dis; 1990 Oct; 16(4):324-8. PubMed ID: 2220779 [TBL] [Abstract][Full Text] [Related]
35. Biomarker classification, validation, and what to look for in 2017 and beyond. Davis JW BJU Int; 2017 May; 119(5):812-814. PubMed ID: 28117555 [No Abstract] [Full Text] [Related]
37. [Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma]. Eisenhardt A; Ohlmann CH; Doehn C Urologe A; 2020 May; 59(5):533-543. PubMed ID: 32300817 [TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as regulators of signal transduction in urological tumors. Fendler A; Stephan C; Yousef GM; Jung K Clin Chem; 2011 Jul; 57(7):954-68. PubMed ID: 21632885 [TBL] [Abstract][Full Text] [Related]
39. Bibliography. Current world literature. Oncology: prostate and renal. Curr Opin Urol; 2000 Sep; 10(5):508-28. PubMed ID: 11005456 [No Abstract] [Full Text] [Related]